Skip to content
Home/Companies/Biotech/Fusion Antibodies
FA

Fusion Antibodies

Biotech·United Kingdom·Exited 2017·Held 4yr

Fusion Antibodies is a biotech company, headquartered in United Kingdom.

Entry
2013
Hold
4yr
Exit
2017
Est. EV
–

Who owns Fusion Antibodies?

Fusion Antibodies was owned by Clarendon Fund Managers through Co-Fund NI (2012 vintage) from 2013 to 2017, exited via IPO.

Hand-verified · updated 2026-07-08

Clarendon Fund Managers
Investor
Clarendon Fund Managers
Co-Fund NI · 2012 · VC

Key facts

HQUnited Kingdom
SectorBiotech
StatusAcquired
Exit Type
IPO
Buyer
–
MOIC
–
Exit Year
2017

More from Co-Fund NI

Other portfolio companies in the same fund.

Aflo
Active
MedTechUnited Kingdom
Antennaware
Active
Deep TechUnited Kingdom
Automated Intelligence
Active
SoftwareUnited Kingdom
Blinky
Active
ConsumerUnited Kingdom
Bubblebum
Active
ConsumerUK
CADshare
Active
SoftwareUK

More PE-backed in Biotech

Comparable biotech deals from other GPs.

GenSight Biologics
Active
Sofinnova PartnersFrance
InBrain Pharma
Active
Finovam GestionFrance
Isavy Biotech
Active
Ring CapitalFrance
NeoVacs
Active
Odyssée VentureFrance
ReNeuron Group
Exited 2024
Obotritia CapitalUnited Kingdom
Univercells
Exited 2023
AdBio PartnersBelgium
to
Data refreshed weekly · Sourced from public filings